Level A· Stronger Clinical EvidenceSystematic ReviewEurope PMCOpen access

Cardiac sympathetic hyperinnervation after myocardial infarction: a systematic review and qualitative analysis

Chen HS., van Roon L., Schoones J., Zeppenfeld K., DeRuiter MC., Jongbloed MRM.

Systematic Review on Cardiovascular Disease, Scar, published in Ann Med (2023) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Systematic Review
Journal
Ann Med (2023)
Reported sample size
—
Source database
Europe PMC
PMID
38065671
PMCID
PMC10836288
DOI
10.1080/07853890.2023.2283195
Citations
8

Abstract (original English)

Background Cardiac sympathetic hyperinnervation after myocardial infarction (MI) is associated with arrhythmogenesis and sudden cardiac death. The characteristics of cardiac sympathetic hyperinnervation remain underexposed. Objective To provide a systematic review on cardiac sympathetic hyperinnervation after MI, taking into account: (1) definition, experimental model and quantification method and (2) location, amount and timing, in order to obtain an overview of current knowledge and to expose gaps in literature. Methods References on cardiac sympathetic hyperinnervation were screened for inclusion. The included studies received a full-text review and quality appraisal. Relevant data on hyperinnervation were collected and qualitatively analysed. Results Our literature search identified 60 eligible studies performed between 2000 and 2022. Cardiac hyperinnervation is generally defined as an increased sympathetic nerve density or increased number of nerves compared to another control group (100%). Studies were performed in a multitude of experimental models, but most commonly in male rats with permanent left anterior descending (LAD) artery ligation (male: 63%, rat: 68%, permanent ligation: 93%, LAD: 97%). Hyperinnervation seems to occur mainly in the borderzone. Quantification after MI was performed in regions of interest in µm 2 /mm 2 (41%) or in percentage of nerve fibres (46%

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
HeartSympathetic Nervous SystemAnimalsHumansRatsDeath, Sudden, CardiacMyocardial InfarctionFemaleMaleArrhythmias, Cardiac

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research